FI971326A - tagA-geeni ja menetelmiä mahahaavan ja vatsasyövän alttiuden toteamiseksi - Google Patents
tagA-geeni ja menetelmiä mahahaavan ja vatsasyövän alttiuden toteamiseksi Download PDFInfo
- Publication number
- FI971326A FI971326A FI971326A FI971326A FI971326A FI 971326 A FI971326 A FI 971326A FI 971326 A FI971326 A FI 971326A FI 971326 A FI971326 A FI 971326A FI 971326 A FI971326 A FI 971326A
- Authority
- FI
- Finland
- Prior art keywords
- antigen
- taga
- gastric
- methods
- detecting
- Prior art date
Links
- 206010017758 gastric cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 101150115529 tagA gene Proteins 0.000 title abstract 2
- 208000005718 Stomach Neoplasms Diseases 0.000 title 1
- 208000007107 Stomach Ulcer Diseases 0.000 title 1
- 201000005917 gastric ulcer Diseases 0.000 title 1
- 201000011549 stomach cancer Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 7
- 102000036639 antigens Human genes 0.000 abstract 7
- 108091007433 antigens Proteins 0.000 abstract 7
- 241000590002 Helicobacter pylori Species 0.000 abstract 2
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 abstract 2
- 101100478633 Escherichia coli O157:H7 stcE gene Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000010749 gastric carcinoma Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 201000000498 stomach carcinoma Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/062—Gastritis or peptic ulcer disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/316,397 US5733740A (en) | 1992-10-13 | 1994-09-30 | Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| PCT/US1995/012669 WO1996010639A2 (en) | 1994-09-30 | 1995-09-29 | THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI971326A0 FI971326A0 (fi) | 1997-03-27 |
| FI971326A true FI971326A (fi) | 1997-05-27 |
Family
ID=23228874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971326A FI971326A (fi) | 1994-09-30 | 1997-03-27 | tagA-geeni ja menetelmiä mahahaavan ja vatsasyövän alttiuden toteamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5733740A (es) |
| EP (1) | EP0783579B1 (es) |
| JP (1) | JPH10509864A (es) |
| CN (1) | CN1166858A (es) |
| AT (1) | ATE276365T1 (es) |
| CA (1) | CA2201353A1 (es) |
| CZ (1) | CZ96697A3 (es) |
| DE (1) | DE69533514T2 (es) |
| ES (1) | ES2231792T3 (es) |
| FI (1) | FI971326A (es) |
| HU (1) | HUT76730A (es) |
| MX (1) | MX9702335A (es) |
| NO (1) | NO971473L (es) |
| NZ (1) | NZ295297A (es) |
| PL (1) | PL319441A1 (es) |
| WO (1) | WO1996010639A2 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0967279B1 (en) * | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
| US5733740A (en) * | 1992-10-13 | 1998-03-31 | Vanderbilt University | Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
| US6290962B1 (en) | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
| DE69529219T2 (de) * | 1994-07-01 | 2003-11-06 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Helicobacter proteine und impstoffe |
| WO1997025429A1 (en) * | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
| AU735391B2 (en) * | 1996-11-14 | 2001-07-05 | Human Genome Sciences, Inc. | Helicobacter polypeptides and corresponding polynucleotide molecules |
| US6902903B1 (en) * | 1996-12-19 | 2005-06-07 | Chiron Corporation | Helicobacter pylori diagnostics |
| TWI237695B (en) * | 1999-12-14 | 2005-08-11 | Joy Biomedical Corp | Helicobacter pylori antigens in blood |
| CA2458854A1 (en) * | 2001-08-31 | 2003-03-06 | Chiron Srl | Helicobacter pylori vaccination |
| FI118061B (fi) * | 2001-09-24 | 2007-06-15 | Beanor Oy | Menetelmä ja bioanturi analyysiä varten |
| WO2003060121A2 (en) * | 2001-12-21 | 2003-07-24 | Diadexus, Inc. | Compositions and methods relating to gastric specific genes and proteins |
| FI115166B (fi) * | 2001-12-31 | 2005-03-15 | Biofons Oy | Diagnostisia menetelmiä |
| WO2003080840A1 (fr) * | 2002-03-26 | 2003-10-02 | Peking University School Of Oncology | Procede d'inspection de la susceptibilite genetique du carcinome gastrique associe a h.pylori et son utilisation |
| TWI276631B (en) * | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| US20040142379A1 (en) | 2003-01-16 | 2004-07-22 | Carlsberg Research Laboratory | Affinity fishing for ligands and proteins receptors |
| EP1789094B1 (en) | 2004-08-13 | 2014-12-10 | MARSHALL, Barry J. | Bacterial delivery system |
| US8029777B2 (en) | 2004-08-13 | 2011-10-04 | Marshall Barry J | Helicobacter system and uses thereof |
| US9568471B2 (en) * | 2005-01-25 | 2017-02-14 | The Johns Hopkins University | Plasmodium diagnostic assay device |
| JP2022184246A (ja) * | 2021-05-31 | 2022-12-13 | 株式会社日立製作所 | データ抽出システムおよびデータ抽出方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262156A (en) * | 1991-08-12 | 1993-11-16 | Hycor Biomedical, Inc. | Antigenic compositions and their use for the detection of Helicobacter pylori |
| EP0967279B1 (en) * | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| US5403924A (en) * | 1992-10-13 | 1995-04-04 | Vanderbilt University | Taga gene and methods for detecting predisposition to peptic ulceration |
| US5733740A (en) * | 1992-10-13 | 1998-03-31 | Vanderbilt University | Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
-
1994
- 1994-09-30 US US08/316,397 patent/US5733740A/en not_active Expired - Lifetime
-
1995
- 1995-09-29 CZ CZ97966A patent/CZ96697A3/cs unknown
- 1995-09-29 AT AT95936850T patent/ATE276365T1/de not_active IP Right Cessation
- 1995-09-29 DE DE69533514T patent/DE69533514T2/de not_active Expired - Fee Related
- 1995-09-29 ES ES95936850T patent/ES2231792T3/es not_active Expired - Lifetime
- 1995-09-29 EP EP95936850A patent/EP0783579B1/en not_active Expired - Lifetime
- 1995-09-29 CA CA002201353A patent/CA2201353A1/en not_active Abandoned
- 1995-09-29 CN CN95196382A patent/CN1166858A/zh active Pending
- 1995-09-29 MX MX9702335A patent/MX9702335A/es not_active IP Right Cessation
- 1995-09-29 NZ NZ295297A patent/NZ295297A/xx unknown
- 1995-09-29 JP JP8512113A patent/JPH10509864A/ja not_active Ceased
- 1995-09-29 HU HU9701326A patent/HUT76730A/hu unknown
- 1995-09-29 WO PCT/US1995/012669 patent/WO1996010639A2/en active IP Right Grant
- 1995-09-29 PL PL95319441A patent/PL319441A1/xx unknown
-
1997
- 1997-03-27 FI FI971326A patent/FI971326A/fi unknown
- 1997-04-01 NO NO971473A patent/NO971473L/no not_active Application Discontinuation
-
1998
- 1998-03-02 US US09/034,306 patent/US5876943A/en not_active Expired - Lifetime
-
1999
- 1999-03-01 US US09/259,437 patent/US6153390A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU703075B2 (en) | 1999-03-11 |
| MX9702335A (es) | 1997-10-31 |
| PL319441A1 (en) | 1997-08-04 |
| NO971473D0 (no) | 1997-04-01 |
| HUT76730A (en) | 1997-11-28 |
| NO971473L (no) | 1997-05-29 |
| US6153390A (en) | 2000-11-28 |
| CZ96697A3 (en) | 1997-10-15 |
| CN1166858A (zh) | 1997-12-03 |
| NZ295297A (en) | 1999-03-29 |
| EP0783579A2 (en) | 1997-07-16 |
| DE69533514D1 (de) | 2004-10-21 |
| CA2201353A1 (en) | 1996-04-11 |
| JPH10509864A (ja) | 1998-09-29 |
| EP0783579B1 (en) | 2004-09-15 |
| WO1996010639A3 (en) | 1996-05-17 |
| DE69533514T2 (de) | 2005-09-15 |
| WO1996010639A2 (en) | 1996-04-11 |
| FI971326A0 (fi) | 1997-03-27 |
| ES2231792T3 (es) | 2005-05-16 |
| ATE276365T1 (de) | 2004-10-15 |
| US5733740A (en) | 1998-03-31 |
| US5876943A (en) | 1999-03-02 |
| AU3858995A (en) | 1996-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971326A (fi) | tagA-geeni ja menetelmiä mahahaavan ja vatsasyövän alttiuden toteamiseksi | |
| AU2706384A (en) | Colorimetric immunoassay on solid surface | |
| ATE152524T1 (de) | Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung | |
| EP0325045A3 (en) | Immunoassay method for detecting antigens | |
| DE3579841D1 (de) | Multisites immunometrisches testverfahren. | |
| ATE12010T1 (de) | Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer. | |
| NZ330475A (en) | Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation | |
| ES483606A1 (es) | Metodo y su correspondiente kit de prueba para la deteccion-y-o determinacion de una inmunoglobulina especifica antige- nica. | |
| NO962084L (no) | DNA sekvens som koder for en BMP reseptor | |
| KR930016439A (ko) | 시이엔피-비(cenp-b)항원 결정부 | |
| JPS5794660A (en) | Measurement of inhibitor-enzyme compound | |
| ES484166A1 (es) | Procedimiento para la deteccion y determinacion de un anti- cuerpo fijador del complemento | |
| DK414386A (da) | Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse | |
| SE8502722L (sv) | Sett att bestemma fc-dels-bindande bakteriella polypeptider | |
| EP0250119A3 (en) | Atherosclerotic anti-idiotype antibody immunoassay and reagents | |
| EP0219279A3 (en) | A reagent for detection and measurement of acetaldehyde-protein condensates in a fluid, together with its preparation and method of use | |
| FI943816A (fi) | Menetelmä ja välineistö vasta-aineiden määrittämiseksi | |
| Ketyi et al. | Enzyme-linked immunosorbent assay/ELISA/ for detection of crude heat-labile enterotoxins of Escherichia coli. | |
| Caton et al. | Immunosubtractive Electrophoresis on Gradient Polyacrylamide Gels | |
| Cover et al. | Taga gene and methods for detecting predisposition to peptic ulceration | |
| HUT53230A (en) | Method for radioimmunological detecting prostaglandin e down 2 content | |
| DE68921184D1 (de) | Enzym-Quantifizierungstest auf einem Docht. | |
| PT79505A (en) | Protection of antibody during chemical modification |